1. Home
  2. JCSE vs LYRA Comparison

JCSE vs LYRA Comparison

Compare JCSE & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCSE
  • LYRA
  • Stock Information
  • Founded
  • JCSE 1999
  • LYRA 2005
  • Country
  • JCSE Singapore
  • LYRA United States
  • Employees
  • JCSE N/A
  • LYRA N/A
  • Industry
  • JCSE Miscellaneous manufacturing industries
  • LYRA Medical/Dental Instruments
  • Sector
  • JCSE Consumer Discretionary
  • LYRA Health Care
  • Exchange
  • JCSE Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • JCSE 5.6M
  • LYRA 6.1M
  • IPO Year
  • JCSE 2022
  • LYRA 2020
  • Fundamental
  • Price
  • JCSE $0.90
  • LYRA $0.11
  • Analyst Decision
  • JCSE
  • LYRA Hold
  • Analyst Count
  • JCSE 0
  • LYRA 4
  • Target Price
  • JCSE N/A
  • LYRA $1.25
  • AVG Volume (30 Days)
  • JCSE 26.5K
  • LYRA 1.8M
  • Earning Date
  • JCSE 05-06-2025
  • LYRA 05-06-2025
  • Dividend Yield
  • JCSE 9.94%
  • LYRA N/A
  • EPS Growth
  • JCSE N/A
  • LYRA N/A
  • EPS
  • JCSE 0.12
  • LYRA N/A
  • Revenue
  • JCSE $14,723,999.00
  • LYRA $1,534,000.00
  • Revenue This Year
  • JCSE N/A
  • LYRA N/A
  • Revenue Next Year
  • JCSE N/A
  • LYRA $237.15
  • P/E Ratio
  • JCSE $7.29
  • LYRA N/A
  • Revenue Growth
  • JCSE N/A
  • LYRA N/A
  • 52 Week Low
  • JCSE $0.67
  • LYRA $0.08
  • 52 Week High
  • JCSE $2.39
  • LYRA $5.65
  • Technical
  • Relative Strength Index (RSI)
  • JCSE 35.69
  • LYRA 42.33
  • Support Level
  • JCSE $0.89
  • LYRA $0.08
  • Resistance Level
  • JCSE $1.10
  • LYRA $0.10
  • Average True Range (ATR)
  • JCSE 0.16
  • LYRA 0.01
  • MACD
  • JCSE 0.00
  • LYRA 0.00
  • Stochastic Oscillator
  • JCSE 4.31
  • LYRA 62.16

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: